{
  "name": "aging-research",
  "version": "1.0.0",
  "description": "AgingResearchAI - Multi-LLM system for aging and metabolic disease drug discovery. Use for T2D, NAFLD/NASH, Sarcopenia research with literature-grounded claims and ADMET predictions.",
  "triggers": [
    "aging research",
    "drug discovery",
    "T2D pathogenesis",
    "NAFLD",
    "sarcopenia",
    "ADMET prediction",
    "scientific debate",
    "PubMed search"
  ],
  "instructions_file": "../skills/aging-research.md",
  "tools_required": ["Bash", "Read", "Write", "Edit"],
  "environment": {
    "PYTHONPATH": ".",
    "requires_api_keys": [
      "GOOGLE_API_KEY",
      "DEEPSEEK_API_KEY",
      "KIMI_API_KEY"
    ]
  },
  "examples": [
    {
      "user": "Search for papers on AMPK and insulin resistance",
      "action": "Use RAG to search PubMed and retrieve relevant literature with PMIDs"
    },
    {
      "user": "Is metformin's primary mechanism through AMPK activation?",
      "action": "Run multi-LLM debate to verify this claim with literature context"
    },
    {
      "user": "Check ADMET properties of this compound: CC(=O)Nc1ccc(O)cc1",
      "action": "Run quick_admet_check for acetaminophen SMILES"
    },
    {
      "user": "What are the key pathways in T2D liver pathogenesis?",
      "action": "Run pathogenesis discovery pipeline for T2D in liver tissue"
    }
  ]
}
